Zenas BioPharma (ZBIO) EV/EBITDA: History & Chart

Zenas BioPharma, Inc.(ZBIO)

Biotechnology · Waltham, MA

$26.94-0.89 (-3.20%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Zenas BioPharma, Inc.

Zenas BioPharma, Inc. functions as a clinical-stage biopharmaceutical firm, concentrating on the creation and market introduction of innovative, immunology-based treatments. The company's primary investigational therapy is obexelimab, a distinctive bifunctional monoclonal antibody intended to address multiple diseases such as immunoglobulin G4-related disease, multiple sclerosis, systemic lupus erythematosus, and warm autoimmune hemolytic anemia. Its developmental portfolio also features ZB002, an anti-TNFa monoclonal antibody; ZB004, a cytotoxic T-lymphocyte-associated antigen 4-immunoglobulin fusion; ZB001, an anti-insulin-like growth factor-1 receptor monoclonal antibody; and ZB005, an anti-active complement component 1s monoclonal antibody. Established in 2019, the entity was formerly recognized as Zenas BioPharma (Cayman) Limited before adopting its current name, Zenas BioPharma, Inc., in August 2023. Its headquarters are located in Waltham, Massachusetts.

Waltham, MA

167 employees

zenasbio.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Leon Oliver Moulder Jr.

View full financials

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
Zenas BioPharma, Inc. (ZBIO)	$1.70B	N/A	N/A	N/A	N/A
DENTSPLY SIRONA Inc. (XRAY)vs ›	$1.71B	4.43x	6.94x	36.47x	27.65x
Personalis, Inc. (PSNL)vs ›	$1.71B	N/A	N/A	N/A	N/A
Intellia Therapeutics, Inc. (NTLA)vs ›	$1.73B	N/A	N/A	N/A	N/A
Alignment Healthcare, Inc. (ALHC)vs ›	$1.74B	15.87x	130.62x	220.82x	220.82x
Xeris Biopharma Holdings, Inc. (XERS)vs ›	$1.74B	38.84x	89.00x	147.22x	147.22x
Absci Corporation (ABSI)vs ›	$1.74B	N/A	N/A	N/A	N/A
Novocure Ltd (NVCR)vs ›	$1.74B	N/A	2603.44x	1662.57x	1662.57x
Surgery Partners, Inc. (SGRY)vs ›	$1.75B	9.62x	10.11x	12.56x	13.71x
Generate Biomedicines, Inc. (GENB)vs ›	$1.77B	N/A	N/A	N/A	N/A

NAME

MARKET CAP

EV/EBITDA RATIO

TTM

Zenas BioPharma, Inc. (ZBIO)

$1.70B

N/A

DENTSPLY SIRONA Inc. (XRAY)vs ›

$1.71B

4.43x

6.94x

36.47x